Why Cannabis Stocks Are About to Explode in 2026

Why Cannabis Stocks Are About to Explode in 2026

The Historic Listing of US Cannabis Stocks

Introduction to the Momentous Event

  • On June 10th, 2026, Trulieve Cannabis became the first US cannabis company to list on the New York Stock Exchange under ticker TRLV, marking a significant milestone in American cannabis history.
  • Investors are questioning whether this is the right time to invest in US cannabis stocks or if they have missed their opportunity.

Overview of the Video's Purpose

  • Teddy, an experienced investor with over ten years in trading, aims to provide insights and analysis on US cannabis stocks to help viewers avoid costly mistakes.
  • The video will cover Trulieve's journey to listing, legal developments from December 2025 onward, market size insights, industry catalysts for growth, and recommended stocks and ETFs.

Understanding Trulieve's Uplisting Strategy

How Trulieve Achieved Its NYSE Listing

  • Trulieve circumvented federal restrictions by structuring its operations through Harvest Enterprises LLC, allowing it to separate recreational cannabis from its balance sheet. This maneuver addressed NYSE concerns about illegal operations.
  • By transferring operational control of recreational activities, Trulieve was able to meet NYSE requirements for listing without waiting for federal legalization changes.

Legal Developments Impacting Cannabis Investment

Current Legal Status of Cannabis

  • Medical cannabis is now classified as Schedule III federally due to recent legal changes; however, recreational cannabis remains classified as Schedule I with no recognized medical use.
  • Key legal events include an executive order from December 18th, 2025, that initiated rescheduling discussions and a formal reclassification signed by AG Todd Blanche on April 23rd, 2026. This marked a historic acknowledgment of medical cannabis use by the federal government.

Market Size and Growth Potential

The Expanding Cannabis Market Landscape

  • Analysts often underestimate the true potential of the cannabis market by only comparing it within itself; it competes against multiple industries including alcohol (a $1.7 trillion market), tobacco ($59 billion), and OTC pain relief ($31 billion).
  • For instance:
  • Daily cannabis users have surpassed daily alcohol drinkers in the U.S., indicating a shift in consumer behavior towards cannabis products over traditional alcohol consumption.
  • Opioid prescriptions have decreased significantly in states with legalized medical marijuana usage due to patients opting for cannabis alternatives instead.

Industry Tailwinds Supporting Growth

Five Key Factors Driving Cannabis Stock Prices Higher

  1. Tax Relief: The removal of Section 280E tax penalties allows medical operators significant savings estimated at $2.3 billion annually which can be reinvested into business growth rather than taxes paid on revenue rather than profit.
  1. Banking Access: Federal recognition opens pathways for banking services previously unavailable due to strict regulations surrounding federally illegal substances; this could stabilize cash flow management for operators moving forward.
  1. Index Fund Inclusion: With medical status recognized federally and successful listings like Trulieve’s paving the way for index fund eligibility—potentially unlocking trillions in investment capital into this sector—cannabis companies may see increased stock prices as institutional investors gain access.[]
  1. Institutional Investment Opportunities: Institutional funds can now consider investing in federally recognized entities like those listed on major exchanges such as NYSE after regulatory barriers were lifted.[]
  1. Proven Gateway Structure: The success of Trulieve demonstrates that other multi-state operators can replicate similar structures without needing full federal legalization immediately.[]

Upcoming Events That Could Influence Investments

Six Catalysts Worth Watching

  1. DEA Hearing Outcome (July 15th): A pivotal event determining whether recreational cannabis will also move to Schedule III status alongside medical use; outcomes here could significantly impact stock valuations across the board.[]
  1. Future NYSE Listings: Following Trulieve’s lead could trigger further uplistings among other major players leading potentially massive passive buying pressure from index funds.[]
  1. SAFE Banking Act Passage: If passed again through Congress would allow commercial banking access which would lower costs across operations significantly impacting profitability positively.[]
  1. IRS Guidance on Tax Recovery: Potential retroactive guidance regarding Section 280E could allow companies recovering overpaid taxes during previous classifications leading up until now.

5 . Pennsylvania Adult Use Legislation : Should adult-use legislation pass , existing operators stand ready capitalize immediately expanding their addressable markets overnight .[]

6 . Major Acquisitions by CPG or Pharma Companies: Any acquisition signals validation within broader markets prompting immediate repricing across sectors involved .[]

Understanding Cannabis Production Stages

Breakdown of Production Steps

1 . Stage One - Farming : Controlled environments grow both medicinal & recreational strains ensuring quality standards maintained throughout production process .[]

2 . Stage Two - Processing : Raw materials transformed into consumables adding value before reaching consumers ; branding plays crucial role here maximizing margins retained per sale made .[]

3 . Stage Three - Distribution : Licensed distributors manage compliance paperwork while transporting goods legally ensuring smooth transitions between factories & retail outlets []

4 . Stage Four - Retail Dispensaries : Where final product reaches customers ; differences exist between medicinal pharmacies versus recreational shops competing based experience offered along with selection available []

5 . Stage Five – Ancillary Services : Companies providing support functions without handling plants directly face less risk but also capture limited upside compared competitors controlling entire chain []

(T1210S) Recommended Stocks and ETFs

Top Picks Based on Value Chain Positioning

Vertically Integrated Operators

  • Trulieve (TRLV): First mover advantage being listed publicly while dominating Florida’s lucrative market makes them attractive long-term play going forward.( T1235S )

Other Notable Multi-State Operators

  • Green Thumb Industries (GTBIF): Established player showing profitability amidst competition.

Cultivation-Focused Operator

  • Glass House Brands (GLASF): Positioned well if California resolves inefficiencies affecting current pricing models.

Real Estate Investment Trust Options

1 . Innovative Industrial Properties (IIPR): Provides dividends while focusing solely real estate aspect supporting cultivation facilities .

2.New Lake Capital Partners(NLCP): Similar model offering financing solutions targeting licensed operators .

ETF Option

-MSOS offers broad exposure encompassing major MSOs without needing pick individual names thus reducing risk associated picking single stocks .

(T1451S) Evaluating Your Investment Approach

Framework for Making Positions

1 . Market Momentum Analysis helps gauge overall sector health confirming moves before entering positions .

2.Technical Analysis identifies key levels where risks defined clearly aiding decision-making processes .

3.Valuation Contextualizes whether specific stock appears cheap/expensive relative peers helping inform choices made .

4.Company-Specific Analysis determines which firms positioned best benefit upcoming catalysts ensuring informed decisions taken when investing .

In conclusion , understanding these dynamics provides clarity around potential opportunities present within evolving landscape surrounding us-cannabis industry today !

Video description

Cannabis stocks just had their biggest regulatory shift in years. Trulieve became the first MSO to list on the NYSE (and now GLASF). Medical cannabis moved toward Schedule III, and a wave of catalysts is lining up for 2026. In this video, I break down what actually happened, why it matters, the value chain behind the industry, the best cannabis stocks and ETFs to watch, and how I'm thinking about positioning. 📩 I send a FREE daily Market Brief — deeper analysis, catalysts, and the names I'm watching: https://investwithteddy.com 🚀 Market Brief Pro is coming — join the waitlist: https://investwithteddy.com What you'll learn: • The NYSE/Schedule III shift • The 2026 legal timeline and the catalysts that move these stocks • How the cannabis value chain works • The MSOs, REITs, and ETFs on my watchlist (TRLV, GTBIF, GLASF, VRNOD, CURLF, IIPR, NLCP, MSOS & more) • A framework for how to position — not a hot-tip list ⏱️ Timestamps: 00:00 - Intro 01:21 - What Just Happened for Cannabis Stocks 02:44 - The Legal Timeline of Cannabis 05:33 - What Is the Cannabis Market Actually Worth? 08:47 - Tailwinds Supporting Legalization 12:37 - Catalysts That Move Cannabis Stocks Higher 16:05 - How Cannabis Is Produced 19:55 - Best Cannabis Stocks & ETFs to Watch 24:26 - How to Position in Cannabis Stocks 25:45 - Should You Invest in Cannabis? 👍 If this helped, like and subscribe — it's the best way to support the channel. ⚠️ Disclaimer: This video is for entertainment, educational and informational purposes only and is NOT financial, investment, tax, or legal advice. Cannabis stocks are highly speculative and volatile, and you can lose money. Tickers mentioned are examples for discussion, not recommendations. Do your own research and consult a licensed professional before investing. I may hold positions in securities mentioned.